BPA Call 36C24222A0007-36C24224N0380
Award Date
11/17/23
Potential Completion Date
11/16/24
Potential Value
$100K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Optum Pharmacy 801, Inc.
Ultimate Awardee
Unitedhealth Group Incorporated
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85085, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
This federal contract award is for 503A pharmaceutical drug compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The award has a ceiling value of $119,448.79 and is a delivery order contract with a firm fixed price pricing type. The ultimate completion date for the contract is August 24, 2024. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service...
The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $216,982.32 firm fixed-price definitive contract for compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, which has no set-aside designation, was awarded on December 26, 2019 with a completion date of December 25, 2020. As the prime contractor, Avella Specialty Pharmacy will provide specialized...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, is for PHARMACY COMPOUNDING services valued at $1,105,798.44. The contract supports the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is a Delivery Order under a Firm Fixed Price contract type. Avella, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services, including chemotherapy...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $75,000.00 firm fixed-price delivery order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for 503A pharmaceutical drug compounding services, including the compounding and delivery of customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications to support VA...
This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for the provision of custom dosed chemotherapy intravenous (IV) medications to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $132,504.84 firm fixed price purchase order has a period of performance through June 30, 2024. Avella Specialty Pharmacy is a subsidiary of UnitedHealth Group Incorporated and operates as a 503A certified pharmacy, specializing...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for $100,000.00 to provide pharmacy compounding services for the Dallas and Amarillo VA Medical Centers through May 31, 2025. Avella, as the prime contractor, will compound customized chemotherapy agents, hazardous sterile...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) is for chemotherapy compounding services for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $97,052.49 and a performance period running through November 16, 2024. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy agents, hazardous sterile preparations,...
This is a delivery order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs (VA), to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy. The contract is for short-term chemotherapy services, with a firm fixed price of $567,000.00 and a period of performance through September 30, 2025. Optum Pharmacy 801, Inc. is a subsidiary of UnitedHealth Group Incorporated, a large diversified health care...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. This BPA call, valued at $500,000.00, is for the renewal of a contract to provide chemotherapy compounding services over a one-year period of performance ending on November 16, 2023. Avella will perform the work at its own facilities to support VA...